Guylaine Henry

670 total citations
13 papers, 341 citations indexed

About

Guylaine Henry is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Guylaine Henry has authored 13 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 5 papers in Oncology and 5 papers in Immunology. Recurrent topics in Guylaine Henry's work include Acute Myeloid Leukemia Research (4 papers), Immune Cell Function and Interaction (4 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Guylaine Henry is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Immune Cell Function and Interaction (4 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Guylaine Henry collaborates with scholars based in France, United States and United Kingdom. Guylaine Henry's co-authors include Nicolas Dulphy, Antoine Toubert, Zena Khaznadar, Jean‐Michel Cayuela, Hervé Dombret, Sophie Agaugué, Emmanuel Raffoux, Nicolas Boissel, Robert Larsson and Hans Liedholm and has published in prestigious journals such as Blood, The Journal of Immunology and European Journal of Immunology.

In The Last Decade

Guylaine Henry

13 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guylaine Henry France 10 182 160 92 48 42 13 341
Samah Nassereddine United States 9 74 0.4× 199 1.2× 78 0.8× 118 2.5× 66 1.6× 20 375
Tobias Terzer Germany 7 65 0.4× 105 0.7× 55 0.6× 112 2.3× 49 1.2× 13 295
Rony Abou Jawde United States 8 74 0.4× 261 1.6× 100 1.1× 91 1.9× 100 2.4× 11 355
M. Puntous France 11 40 0.2× 220 1.4× 95 1.0× 70 1.5× 52 1.2× 34 318
Stéphanie E. Reitsma United States 10 88 0.5× 126 0.8× 26 0.3× 29 0.6× 114 2.7× 17 258
M. Dicato Luxembourg 8 59 0.3× 71 0.4× 65 0.7× 23 0.5× 84 2.0× 20 243
A. Zuiable United Kingdom 8 38 0.2× 310 1.9× 121 1.3× 94 2.0× 46 1.1× 13 348
Amr Hanbali United States 9 32 0.2× 104 0.7× 74 0.8× 108 2.3× 28 0.7× 43 301
Anna Baraldi Italy 9 24 0.1× 88 0.6× 87 0.9× 58 1.2× 43 1.0× 27 256
Waleed Sabry Canada 10 33 0.2× 143 0.9× 98 1.1× 93 1.9× 21 0.5× 23 266

Countries citing papers authored by Guylaine Henry

Since Specialization
Citations

This map shows the geographic impact of Guylaine Henry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guylaine Henry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guylaine Henry more than expected).

Fields of papers citing papers by Guylaine Henry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guylaine Henry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guylaine Henry. The network helps show where Guylaine Henry may publish in the future.

Co-authorship network of co-authors of Guylaine Henry

This figure shows the co-authorship network connecting the top 25 collaborators of Guylaine Henry. A scholar is included among the top collaborators of Guylaine Henry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guylaine Henry. Guylaine Henry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Henry, Guylaine. (2019). Harmonisation des pratiques pour la prévention des infections associées aux soins (IAS) et ergothérapie. 73. 23–36. 1 indexed citations
2.
Khaznadar, Zena, Nicolas Boissel, Sophie Agaugué, et al.. (2015). Defective NK Cells in Acute Myeloid Leukemia Patients at Diagnosis Are Associated with Blast Transcriptional Signatures of Immune Evasion. The Journal of Immunology. 195(6). 2580–2590. 70 indexed citations
3.
Khaznadar, Zena, Guylaine Henry, Niclas Setterblad, et al.. (2014). Acute myeloid leukemia impairs natural killer cells through the formation of a deficient cytotoxic immunological synapse. European Journal of Immunology. 44(10). 3068–3080. 42 indexed citations
4.
5.
Henry, Guylaine, Daniela Géromin, Zena Khaznadar, et al.. (2013). At diagnosis, diffuse large B‐cell lymphoma patients show impaired rituximab‐mediated NK‐cell cytotoxicity. European Journal of Immunology. 43(5). 1383–1388. 20 indexed citations
6.
Haas, Philippe, Pascale Loiseau, Ryad Tamouza, et al.. (2010). NK-cell education is shaped by donor HLA genotype after unrelated allogeneic hematopoietic stem cell transplantation. Blood. 117(3). 1021–1029. 51 indexed citations
7.
Moreland, Larry W., Dorothy McCabe, J R Caldwell, et al.. (2000). Phase I/II trial of recombinant methionyl human tumor necrosis factor binding protein PEGylated dimer in patients with active refractory rheumatoid arthritis.. PubMed. 27(3). 601–9. 33 indexed citations
8.
Eason, Charles, et al.. (1989). The comparative pharmacokinetics and gastric toxicity of bezafibrate and ciprofibrate in the rat. Xenobiotica. 19(8). 913–925. 12 indexed citations
9.
Eason, Charles, et al.. (1988). The relationship between the pharmacokinetics of amrinone in the marmoset and platelet effects. European Journal of Drug Metabolism and Pharmacokinetics. 13(2). 129–133. 2 indexed citations
10.
Larsson, Robert, et al.. (1986). Pharmacokinetics and effects on blood pressure of a single oral dose of milrinone in healthy subjects and in patients with renal impairment. European Journal of Clinical Pharmacology. 29(5). 549–553. 35 indexed citations
11.
Slevin, M L, A. Z. S. Rohatiner, Harpal S. Dhaliwal, et al.. (1982). A comparison of two schedules of cytosine arabinoside used in combination with adriamycin and 6-thioguanine in the treatment of acute myelogenous leukemia. Medical and Pediatric Oncology. 10(S1). 185–192. 9 indexed citations
12.
Bell, Richard, A. Z. S. Rohatiner, M L Slevin, et al.. (1982). Short-term treatment for acute myelogenous leukaemia.. BMJ. 284(6324). 1221–1224. 40 indexed citations
13.
Lister, Tim, S.A. Johnson, Richard Bell, Guylaine Henry, & J. S. Malpas. (1981). Progress in Acute Myeologenous Leukemia. Hämatologie und Bluttransfusion. 26. 38–44. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samah Nassereddine Breakdown of academic impact, for papers by Tobias Terzer Breakdown of academic impact, for papers by Rony Abou Jawde Breakdown of academic impact, for papers by M. Puntous Breakdown of academic impact, for papers by Stéphanie E. Reitsma Breakdown of academic impact, for papers by M. Dicato Breakdown of academic impact, for papers by A. Zuiable Breakdown of academic impact, for papers by Amr Hanbali Breakdown of academic impact, for papers by Anna Baraldi Breakdown of academic impact, for papers by Waleed Sabry
Rankless by CCL
2026